Cargando…
Validation of immunoassays for the Chlamydia trachomatis antigen Pgp3 using a chimeric monoclonal antibody
Seroepidemiology, or measuring antibodies to pathogens to estimate population-level exposure, can provide useful public health data. The tests used, however, often lack sufficient validation data due to absence of a gold standard. For many pathogens, serum antibodies can be detected long after resol...
Autores principales: | Goodhew, Brook, Tang, Xiaoling, Goldstein, Jason, Lee, Joo, Martin, Diana, Gwyn, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160048/ https://www.ncbi.nlm.nih.gov/pubmed/37142607 http://dx.doi.org/10.1038/s41598-023-33834-4 |
Ejemplares similares
-
Comparison of Platforms for Testing Antibody Responses against the Chlamydia trachomatis Antigen Pgp3
por: Gwyn, Sarah, et al.
Publicado: (2017) -
Latent class modeling to compare testing platforms for detection of antibodies against the Chlamydia trachomatis antigen Pgp3
por: Wiegand, Ryan E., et al.
Publicado: (2018) -
The Performance of Immunoassays to Measure Antibodies to the Chlamydia trachomatis Antigen Pgp3 in Different Epidemiological Settings for Trachoma
por: Gwyn, Sarah, et al.
Publicado: (2021) -
Trachoma, Anti-Pgp3 Serology, and Ocular Chlamydia trachomatis Infection in Papua New Guinea
por: Macleod, Colin K, et al.
Publicado: (2020) -
The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children
por: West, Sheila K., et al.
Publicado: (2020)